(Press-News.org) Many scientists dream of making a single discovery that provides fundamental insight into nature, may be used to help save human lives, and can assist in the preservation of an endangered species. In new research reported in the journal Cell, a Japanese team is on the verge of accomplishing this nearly impossible feat.
Unagi, the sea-going Japanese freshwater eel, harbors a fluorescent protein that could serve as the basis for a revolutionary new clinical test for bilirubin, a critical indicator of human liver function, hemolysis, and jaundice, according to researchers from the RIKEN Brain Science Institute. The discovery also sheds light on the mysterious and endangered Unagi that could contribute to its conservation.
Science from kitchen to lab to clinic
Best known as a culinary delicacy in Japan, the freshwater eel Unagi (Anguilla japonica) and related species have seen a worldwide decrease in population, probably due to the effects of global warming, and Unagi is on the brink of extinction in Japan. Yet almost nothing is know about the biology of the eel.
Drs. Atsushi Miyawaki, Akiko Kumagai and their team cloned a gene from Unagi for an unusual fluorescent protein they named UnaG, for Unagi Green protein, that allows eels to glow in the dark . UnaG is the first fluorescent protein found in vertebrates; previously they were thought to exist only in simple animals like jellyfish.
But what makes UnaG truly unique in nature is that it needs a natural chemical to activate its powerful green light emission. In a surprise twist, the compound was identified by the authors to be bilirubin, a slippery molecule universally used in clinical labs around the world as a human blood marker for liver function.
VIDEO:
Unagi, the sea-going Japanese freshwater eel, harbors a fluorescent protein that could serve as the basis for a revolutionary new clinical test for bilirubin, a critical indicator of human liver...
Click here for more information.
New clinical test for bilirubin
Bilirubin is the breakdown product of blood hemoglobin and is toxic if present in excess in the body like in the characteristic yellow skin and eye color conditions seen in newborn babies, jaundice and kernicterus. It is also a common marker in blood tests where bilirubin is used by doctors to assess liver function and for the assessment of health, including hemolysis, the loss of red blood cells in anemia.
By analyzing the structure of UnaG, the team discovered a novel mechanism of fluorescence enabling bilirubin to bind to UnaG and activate its light emission. With this property, they developed a superior new assay for bilirubin with high sensitivity, accuracy and speed that may become the global clinical standard, and can be used in developing countries where child liver health is a major issue.
Role of UnaG in eel conservation
Japanese freshwater eels have a long-distance migration life cycle, growing in inland rivers and swimming far into the sea to spawn. The authors identified UnaG and bilirubin in the muscle cells of Japanese, American, and European eels where they may aid in endurance swimming during migration. The unexpected discovery of UnaG may initiate legislation to conserve endangered eel species.
"We believe that UnaG provides an unexpected foothold into several important but currently obscure areas of human health including bilirubin metabolism and muscle physiology during endurance exercise," Miyawaki concludes. "Before the discovery of UnaG, I couldn't imagine that basic science could have such a direct impact on human health. From a simple eel, we found a new path to the clinic."
INFORMATION:
For more information, please contact:
Juliette Savin
Global Relations Office
RIKEN
Tel: +81-(0)48-462-1225
Mobile phone: +81-(0)808895-2136
Email: pr@riken.jp
Reference
A.Kumagai et al. "A Bilirubin-Inducible Fluorescent Protein from Eel Muscle"
Cell, 2013, DOI: 10.1016/j.cell.2013.05.038
About RIKEN
RIKEN is Japan's largest research institute for basic and applied research. Over 2500 papers by RIKEN researchers are published every year in leading scientific and technical journals, covering a broad spectrum of disciplines including physics, chemistry, biology, medical science and engineering. RIKEN's research environment and strong emphasis on interdisciplinary collaboration and globalization has earned a reputation for scientific excellence worldwide.
Website: http://www.riken.jp/en/ Find us on Twitter at @riken_en
About the RIKEN Brain Science Institute
The RIKEN Brain Science Institute (BSI) performs cutting-edge neuroscience research in the service of society with an international reputation as an innovative center for research and training. Researchers at BSI seek to understand brain functions from molecules to neural circuits to cognition, using methods drawn from a wide range of disciplines. BSI is also leading efforts to provide career opportunities for researchers in Japan and around the world.
New fluorescent protein from eel revolutionizes key clinical assay
2013-06-14
ELSE PRESS RELEASES FROM THIS DATE:
Using math to kill cancer cells
2013-06-14
Ottawa—June 14, 2013—Here's a good reason to pay attention in math class. Nature Communications has published a paper from Ottawa researchers today, outlining how advanced mathematical modelling can be used in the fight against cancer. The technique predicts how different treatments and genetic modifications might allow cancer-killing, oncolytic viruses to overcome the natural defences that cancer cells use to stave off viral infection.
"Oncolytic viruses are special in that they specifically target cancer cells," explains Dr. Bell, a senior scientist at the Ottawa Hospital ...
2013 ESH/ESC Guidelines for the management of arterial hypertension
2013-06-14
Milan, 14 June 2013. Lifestyle factors, lack of awareness by both patients and physicians, hesitancy in initiating and intensifying drug treatment, and healthcare structural deficiencies are amongst the reasons for the increasing problem of high blood pressure in Europe, according to new joint Guidelines issued today by the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). The Guidelines, which recommend several significant changes to hypertension treatment, are launched* today at the European Society of Hypertension congress in Milan, ...
CSHL geneticists solve mystery of EEC Syndrome's variable severity in children
2013-06-14
Cold Spring Harbor, NY – By identifying a protein that acts as a genetic modifier, scientists at Cold Spring Harbor Laboratory (CSHL) have solved the mystery of why some infants are born with a grave syndrome consisting of cleft palate and major deformities of the skin and limbs, while other infants bearing the same predisposing genetic mutation bear little or no sign of the illness, called EEC.
EEC stands for "Ectodactyly, Ectodermal dysplasia, Clefting syndrome." It is rare in its full-blown form, although individual aspects of the associated pathology, such as cleft ...
Nurse-led programs help patients self-manage RA
2013-06-14
Madrid, Spain, 14 June 2013: Data first presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism demonstrate the benefits of a nurse-led programme on patient self-management and the management of rheumatoid arthritis (RA) co-morbidities.
The COMEDRA study was a six-month trial involving patients with RA who attended one of the twenty participating treatment centres in France. Patients were randomly allocated to one of two arms of the trial; the evaluation of nurse-led programmes on patient self-assessment or on the management of co-morbidities.
Within ...
High prevalence of NSAID prescription in those at risk of heart attack/death in primary care
2013-06-14
Madrid, Spain, 14 June 2013: New study data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate a high prevalence of NSAID prescriptions in patients at risk of ischaemic heart disease (IHD).
Published evidence suggest significant cardiovascular implications of NSAIDs for patients, with an immediate mortality risk demonstrated in patients who had suffered a myocardial infarction (MI, heart attack) even when prescribed treatment duration was less than one week.2
NSAIDs are used to relieve pain and signs of inflammation, ...
Overweight and obese patients less likely to achieve remission in early RA
2013-06-14
Madrid, Spain, 14 June 2013: A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that overweight and obese patients are less likely to achieve successful remission in early rheumatoid arthritis (ERA) compared to those of normal weight.
Obese and overweight ERA subjects required 2.4 times more anti-TNF therapy throughout the study than normal weight participants without achieving similar remission outcomes.
RA is a chronic, inflammatory autoimmune disease affecting approximately 1 in 100 people worldwide. RA ...
Novel biomarkers improve diagnosis in rheumatoid arthritis
2013-06-14
Madrid, Spain, 12 June 2013: Data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, show that novel antibody biomarkers could significantly improve diagnosis in rheumatoid arthritis (RA).
Four candidate biomarkers – UH-RA.1, UH-RA.9, UH-RA.14 and UH-RA.21 – were investigated; as a group they demonstrated 85% specificity for RA, and were present in both early and seronegative disease, with 36% of early RA and 24% of RF- and ACCP -negative patients testing positive.
RA is a chronic autoimmune disease characterised by inflammation ...
A turbocharger for nerve cells
2013-06-14
This news release is available in German. Locating a car that's blowing its horn in heavy traffic, channel-hopping between football and a thriller on TV without losing the plot, and not forgetting the start of a sentence by the time we have read to the end – we consider all of these to be normal everyday functions. They enable us to react to fast-changing circumstances and to carry out even complex activities correctly. For this to work, the neuron circuits in our brain have to be very flexible. Scientists working under the leadership of neurobiologists Nils Brose ...
From Botswanan big cats to Surrey house cats
2013-06-14
Scientists who designed GPS tracking collars to study hunting cheetahs in Botswana have miniaturised them to track 50 domestic cats in a Surrey village for a BBC programme. The BBC also deployed cat-cams which were turned on by the collar's activity sensor when the cat was moving. 'The Secret Life of The Cat' is broadcast on BBC Two Horizon on Thursday June 13th 2013 at 21:00.
In a first study of its kind the wanderings of our feline friends were recorded, revealing how far they roamed and what they got up to once they leave their owners behind. The team were concerned ...
Researchers explode the myth about running injuries
2013-06-14
If you are healthy and plan to start running for the first time, it is perfectly all right to put on a pair of completely ordinary 'neutral' running shoes without any special support. Even though your feet overpronate when you run – i.e. roll inwards.
There appears to be no risk that overpronation or underpronation can lead to running injuries through using neutral shoes for this special group of healthy beginners.
This is the result of a study conducted at Aarhus University which has just been published in the British Journal of Sports Medicine under the title "Foot ...